ES375013A1 - Un procedimiento para la preparacion de un nuevo compuesto pirrolobenzodiazepinona. - Google Patents
Un procedimiento para la preparacion de un nuevo compuesto pirrolobenzodiazepinona.Info
- Publication number
- ES375013A1 ES375013A1 ES375013A ES375013A ES375013A1 ES 375013 A1 ES375013 A1 ES 375013A1 ES 375013 A ES375013 A ES 375013A ES 375013 A ES375013 A ES 375013A ES 375013 A1 ES375013 A1 ES 375013A1
- Authority
- ES
- Spain
- Prior art keywords
- formula
- pyrrolobenzodiazepinone
- compound
- derivatives
- arylalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- VRQOSIAJWZNUSL-UHFFFAOYSA-N 2h-pyrrolo[2,3-i][1,2]benzodiazepin-3-one Chemical class C12=NNC(=O)C=CC2=CC=C2C1=CC=N2 VRQOSIAJWZNUSL-UHFFFAOYSA-N 0.000 title 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- -1 pyrrolobenzodiazepinone compound Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8368 | 1968-12-30 | ||
| JP44050780A JPS4843755B1 (enExample) | 1969-06-26 | 1969-06-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES375013A1 true ES375013A1 (es) | 1972-03-01 |
Family
ID=26332992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES375013A Expired ES375013A1 (es) | 1968-12-30 | 1969-12-29 | Un procedimiento para la preparacion de un nuevo compuesto pirrolobenzodiazepinona. |
Country Status (6)
| Country | Link |
|---|---|
| ES (1) | ES375013A1 (enExample) |
| FI (1) | FI46259C (enExample) |
| GB (1) | GB1299198A (enExample) |
| IE (1) | IE33906B1 (enExample) |
| IL (1) | IL33558A (enExample) |
| RO (1) | RO55813A (enExample) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4464467A (en) * | 1982-07-26 | 1984-08-07 | Bristol-Myers Company | Antitumor antibiotics produced by new streptomyces |
| GB9818730D0 (en) | 1998-08-27 | 1998-10-21 | Univ Portsmouth | Collections of compounds |
| ATE240334T1 (de) * | 1998-08-27 | 2003-05-15 | Spirogen Ltd | Pyrrolobenzodiazepine |
| GB9818732D0 (en) | 1998-08-27 | 1998-10-21 | Univ Portsmouth | Collection of compounds |
| US6909006B1 (en) | 1999-08-27 | 2005-06-21 | Spirogen Limited | Cyclopropylindole derivatives |
| GB0226593D0 (en) | 2002-11-14 | 2002-12-24 | Consultants Ltd | Compounds |
| GB0321295D0 (en) | 2003-09-11 | 2003-10-15 | Spirogen Ltd | Synthesis of protected pyrrolobenzodiazepines |
| GB0404577D0 (en) | 2004-03-01 | 2004-04-07 | Spirogen Ltd | Pyrrolobenzodiazepines |
| CA2558195C (en) | 2004-03-01 | 2012-11-06 | Spirogen Limited | 11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines |
| JP5166861B2 (ja) | 2004-03-09 | 2013-03-21 | スピロゲン リミティッド | ピロロベンゾジアゼピン |
| GB0819095D0 (en) | 2008-10-17 | 2008-11-26 | Spirogen Ltd | Pyrrolobenzodiazepines |
| AU2011239522B2 (en) | 2010-04-15 | 2014-10-23 | Medimmune Limited | Targeted pyrrolobenzodiazapine conjugates |
| GB201006340D0 (en) | 2010-04-15 | 2010-06-02 | Spirogen Ltd | Synthesis method and intermediates |
| JP5875083B2 (ja) | 2010-04-15 | 2016-03-02 | メディミューン リミテッド | 増殖性疾患治療用ピロロベンゾジアゼピン |
| AU2012311505B2 (en) | 2011-09-20 | 2016-09-29 | Medimmune Limited | Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates |
| CA2850264C (en) | 2011-10-14 | 2019-11-05 | Spirogen Sarl | Pyrrolobenzodiazepines |
| EA026643B1 (ru) | 2011-10-14 | 2017-04-28 | Сиэтл Дженетикс, Инк. | Пирролбензодиазепины и конъюгаты направленного действия |
| JP6170497B2 (ja) | 2011-10-14 | 2017-07-26 | メドイミューン・リミテッドMedImmune Limited | ピロロベンゾジアゼピン |
| CN103987384A (zh) | 2011-10-14 | 2014-08-13 | 西雅图基因公司 | 吡咯并苯并二氮杂卓和靶向结合物 |
| AU2012322933B2 (en) | 2011-10-14 | 2017-02-02 | Medimmune Limited | Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines |
| CA2885305C (en) | 2012-10-12 | 2019-11-12 | Spirogen Sarl | Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation |
| CA2941485C (en) | 2012-10-12 | 2018-06-12 | Philip Wilson Howard | Pyrrolobenzodiazepines and conjugates thereof |
| US10695433B2 (en) | 2012-10-12 | 2020-06-30 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| EP2906251B1 (en) | 2012-10-12 | 2017-09-27 | ADC Therapeutics SA | Pyrrolobenzodiazepine-anti-cd22 antibody conjugates |
| CA3060520C (en) | 2012-10-12 | 2022-05-17 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| ES2680153T3 (es) | 2012-10-12 | 2018-09-04 | Adc Therapeutics Sa | Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas |
| TR201808051T4 (tr) | 2012-10-12 | 2018-06-21 | Adc Therapeutics Sa | Pirrolobenzodiazepin antikor konjugatları. |
| NZ707486A (en) | 2012-10-12 | 2018-09-28 | Adc Therapeutics Sa | Pyrrolobenzodiazepine - anti-psma antibody conjugates |
| JP6392763B2 (ja) | 2012-10-12 | 2018-09-19 | エイディーシー・セラピューティクス・エス・アーAdc Therapeutics Sa | ピロロベンゾジアゼピン−抗体結合体 |
| US9956299B2 (en) | 2013-10-11 | 2018-05-01 | Medimmune Limited | Pyrrolobenzodiazepine—antibody conjugates |
| EP3054983B1 (en) | 2013-10-11 | 2019-03-20 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| GB201317981D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| WO2015052534A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| GB201416112D0 (en) | 2014-09-12 | 2014-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| MX379396B (es) | 2014-11-25 | 2025-03-11 | Adc Therapeutics Sa | Conjugados de pirrolobenzodiazepina y anticuerpo. |
| GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| GB201506411D0 (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
| GB201601431D0 (en) | 2016-01-26 | 2016-03-09 | Medimmune Ltd | Pyrrolobenzodiazepines |
| GB201602356D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201602359D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| WO2018146189A1 (en) | 2017-02-08 | 2018-08-16 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
| GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
| RS63502B1 (sr) | 2017-04-18 | 2022-09-30 | Medimmune Ltd | Konjugati pirolobenzodiazepina |
| WO2018193102A1 (en) | 2017-04-20 | 2018-10-25 | Adc Therapeutics Sa | Combination therapy with an anti-axl antibody-drug conjugate |
| AU2018285562B2 (en) | 2017-06-14 | 2024-01-18 | Adc Therapeutics Sa | Dosage regimes for the administration of an anti-CD19 ADC |
| HRP20220311T1 (hr) | 2017-08-18 | 2022-05-13 | Medimmune Limited | Konjugati pirolobenzodiazepina |
| GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
| GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| EP3938372B1 (en) | 2019-03-15 | 2023-10-25 | MedImmune Limited | Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer |
-
1969
- 1969-12-17 IL IL33558A patent/IL33558A/xx unknown
- 1969-12-22 FI FI693710A patent/FI46259C/fi active
- 1969-12-24 GB GB62863/69A patent/GB1299198A/en not_active Expired
- 1969-12-29 ES ES375013A patent/ES375013A1/es not_active Expired
- 1969-12-30 IE IE1726/69A patent/IE33906B1/xx unknown
- 1969-12-30 RO RO62025A patent/RO55813A/ro unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI46259C (fi) | 1973-02-12 |
| IL33558A0 (en) | 1970-04-20 |
| RO55813A (enExample) | 1974-02-01 |
| IL33558A (en) | 1973-10-25 |
| IE33906B1 (en) | 1974-12-11 |
| FI46259B (enExample) | 1972-10-31 |
| IE33906L (en) | 1970-06-30 |
| GB1299198A (en) | 1972-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES375013A1 (es) | Un procedimiento para la preparacion de un nuevo compuesto pirrolobenzodiazepinona. | |
| ES310240A1 (es) | Un procedimiento para preparar un indol polinuclear desacilado. | |
| ES457993A1 (es) | Un procedimiento para la preparacion de una isotiazolopiri- dina. | |
| ES388614A1 (es) | Procedimiento para la obtencion de 14 - desoxi - 14 - tosi-loxiacetoxi - mutilina. | |
| ES405456A1 (es) | Un procedimiento para producir 4-hidroximetil-1-ceto-1,2- dihidroftalazina. | |
| FR2240731B1 (enExample) | ||
| ES401898A1 (es) | Procedimiento para la preparacion de derivados de benzofu- rano. | |
| GB1307646A (en) | 5-hydroxycoumarin derivatives | |
| ES442988A1 (es) | Un procedimiento de preparacion de nuevos compuestos de sul-fenamida. | |
| ES391118A1 (es) | Un procedimiento para la preparacion de un nuevo derivado de acido fluoronico. | |
| ES329067A1 (es) | Procedimiento para la preparacion de compuestos heterociclicos. | |
| ES381209A1 (es) | Un procedimiento para preparar nuevas 1,2-difenil-3,5-dio- xo-pirazolidinas sustituidas en la posicion 4. | |
| ES457708A1 (es) | Un procedimiento para la preparacion de un compuesto de 3- hidroximetil-2-cefem. | |
| ES316075A1 (es) | Procedimiento para la produccion de derivados del tropano. | |
| ES461191A1 (es) | Un procedimiento para la preparacion de nuevos derivados de arilcarboxamida. | |
| GB1021530A (en) | Derivatives of 2-oxo-2h-1,4-benzoxazine | |
| ES409594A1 (es) | Procedimiento para la obtencion de derivados dianoicos de la p-fenileno-diamina. | |
| ES293287A1 (es) | Procedimiento de obtención de un nuevo compuesto para el control de la hipertensión | |
| ES331239A3 (es) | Un procedimiento para preparar compuestos de fenotiazina. | |
| ES460287A1 (es) | Un procedimiento para la obtencion de compuestos heterociclicos. | |
| GB1062354A (en) | Manufacture of naphthalene derivatives | |
| ES323103A1 (es) | Un procedimiento para la preparación de nuevas penicilinas. | |
| ES345290A1 (es) | Procedimiento para la produccion de compuestos de fenilci- clohexanona. | |
| ES425046A1 (es) | Un procedimiento para la produccion de nuevos tiazolotria- zolilfosfonotioatos. | |
| ES351814A1 (es) | Procedimiento para la preparacion de canfosulfonatos de de-rivados de la 2,6-dioxopurina. |